ESR1 and breast carcinoma: TNBC shows the worst prognosis compared to other breast cancer types, because of the lack of three therapy-relevant receptors, the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) [22].